January 08, 2026

Microlaser Droplets Deliver Thousands of Viscosity Readouts in Minutes

A new microscopy platform uses vibrating microlasers – made from picoliter droplets – for real-time, high-throughput lipid assessment

The Analytical Scientist

January 06, 2026

GLP-1s: A Quiet Drop-Off in Seniors

For many seniors, breakthrough weight-loss drugs deliver real benefits — until insurance denials, side effects, or muscle loss force them to quit.

KFF Health News

January 02, 2026

Curative Treatment After First-Line Immunotherapy Improves Survival in HCC

Curative treatment—resection, transplantation, and/or local ablation—following first-line immunotherapy is infrequently received, but when it was utilized, it significantly improved overall survival o...

The ASCO Post

January 02, 2026

Which First-Line Systemic Therapy Balances Survival and Quality of Life in Advanced Hepatocellular Carcinoma?

A network meta-analysis reported in JAMA Oncology found that among first-line systemic therapy options, immunotherapy-based combinations offered the most favorable therapeutic balance between survival...

The ASCO Post

December 29, 2025

Addressing the Regulatory Documentation Bottleneck to Transform Drug Approvals

Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.

The Medicine Maker

December 23, 2025

Artificial Tongue Detects Spiciness in Seconds

Milk-derived casein and a conductive hydrogel form a human-inspired sensor for rapid, selective capsaicin detection

The Analytical Scientist

December 22, 2025

Deb Schrag, MD, MPH, FASCO, Elected 2027–2028 ASCO President

Dr. Schrag, a gastrointestinal medical oncologist, is the George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill Cornell Medica...

The ASCO Post

December 11, 2025

Will Spatial Genomics Help Identify Barrett’s Esophagus Patients at High Risk of Esophageal Cancer?

A Keck Medicine of USC expert explains how next-generation genetic analysis could help stratify patients’ cancer risk — and guide treatment decisions.

Keck Medicine of USC

December 11, 2025

GLP-1 drugs pose no cancer risk, review finds

A large systematic review and meta-analysis was limited by a median follow-up of 70 weeks.

Conexiant